Homologous recombination pathway mutations in freshly isolated tumor cells from patients with ovarian cancer correlate with outcome

被引：0
|
作者：
Kessous, R. [1 ]
Octeau, D. [2 ]
Kogan, L. [2 ]
Tonin, P. [1 ]
Laskov, I. [3 ]
Klein, K. [1 ]
Salvador, S. [2 ]
Lau, S. [2 ]
Yasmeen, A. [2 ]
Gotlieb, W. H. [2 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada
[3] Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
373
引用
收藏
页码：167 / 168
页数：3
相关论文
共 50 条
  • [21] The requirement for freshly isolated human tumor cells for the study of colorectal cancer stem cells
    Bellister, Seth Albert
    Fan, Fan
    Tozzi, Federico
    Lu, Jia
    Xia, Ling
    Zhou, Yunfei
    Bhattacharya, Rajat
    Ye, Xiangcang
    Ellis, Lee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [22] The impact of germline and somatic mutations in the homologous recombination repair pathway in pancreatic cancer patients who undergo perioperative chemotherapy
    Jonsdottir, Gudbjorg
    Masson, Asgeir Thor
    Jacobus, Laura S.
    Churchman, Michelle L.
    Edge, Stephen B.
    Noonan, Anne M.
    Cavnar, Michael J.
    Ulahannan, Susanna Varkey
    Sahin, Ibrahim Halil Halil
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [23] Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
    Berckmans, Yani
    Ene, Hila M.
    Ben-Meir, Kerem
    Martinez-Conde, Antonia
    Wouters, Roxanne
    van den Ende, Bieke
    Van Mechelen, Sara
    Monin, Roni
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Dor-On, Eyal
    Haber, Adi
    Weinberg, Uri
    Vergote, Ignace
    Giladi, Moshe
    Coosemans, An
    Palti, Yoram
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer
    Kessous, Roy
    Octeau, David
    Klein, Kathleen
    Tonin, Patricia N.
    Greenwood, Celia M. T.
    Pelmus, Manuela
    Laskov, Ido
    Kogan, Liron
    Salvador, Shannon
    Lau, Susie
    Yasmeen, Amber
    Gotlieb, Walter H.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 553 - 558
  • [25] Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients
    Barberis, Massimo
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (03) : 1 - 3
  • [26] Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
    Wintzell, My
    Hjerpe, Elisabet
    Lundqvist, Elisabeth Avall
    Shoshan, Maria
    BMC CANCER, 2012, 12
  • [27] Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
    My Wintzell
    Elisabet Hjerpe
    Elisabeth Åvall Lundqvist
    Maria Shoshan
    BMC Cancer, 12
  • [28] Improving outcome in homologous recombination competent epithelial ovarian cancer: Hyperthemia and surgeon's perspective
    Mukhopadhyay, Asima
    Abdulrahman, Ganyi
    Davison, Eliza
    Matheson, Elizabeth
    Drew, Yvette
    Curtin, Nicola
    MOLECULAR CANCER RESEARCH, 2017, 15
  • [29] Improving outcome in homologous recombination competent epithelial ovarian cancer: Hyperthemia and surgeon's perspective
    Mukhopadhyay, Asima
    Abdulrahman, Ganyi
    Davison, Eliza
    Matheson, Elizabeth
    Drew, Yvette
    Curtin, Nicola
    MOLECULAR CANCER RESEARCH, 2017, 15
  • [30] Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients
    Feng, Zheng
    Wen, Hao
    Ju, Xingzhu
    Bi, Rui
    Chen, Xiaojun
    Yang, Wentao
    Wu, Xiaohua
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (05)
12345